Inventiva (IVA) Current Taxes (2024 - 2025)
Inventiva (IVA) recorded quarterly Current Taxes of $5.7 million in Q2 2025, up 39.93% quarter-over-quarter from $4.1 million in Q4 2024.
Inventiva (IVA) Current Taxes (2024 - 2025) Analysis & Trends
Inventiva's Current Taxes history runs 2 years deep, the most recent figure standing at $5.7 million for Q2 2025.
- In Q2 2025, Current Taxes changed N/A year-over-year to $5.7 million; the TTM figure through Jun 2025 stood at $5.7 million (changed N/A YoY), while the FY2024 annual figure was $4.1 million, changed N/A from the prior year.
- Current Taxes was $5.7 million for Q2 2025 at Inventiva, up from $4.1 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $5.7 million in Q2 2025 to a low of $4.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 10,460.56 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5.68 Mn |
| Dec 31, 2024 | 4.06 Mn |